Banwarilal Murlidhar Bawri and Family

The Bawri family’s defining strategy is the power of the silent syndicate, building an unlisted pharmaceutical titan through tight family cohesion and a relentless focus on neglected diseases. 

Founded in 1989, Macleods is the product of an enduring partnership between the Bawri and Agarwal families. Led by figures like Banwarilal Murlidhar Bawri and Rajendra Agarwal, the founders consciously chose to fly under the radar. While competitors chased lucrative Western lifestyle drugs, the Macleods families focused on the developing world, becoming a global lifeline for anti-TB, malaria, and HIV medications. 

This collaborative family governance model has proven remarkably resilient. By keeping the company entirely private, the extended family has maintained a nimble decision-making process, growing Macleods into a $1 billion+ revenue giant with over 20,000 employees. As a new generation of Bawris and Agarwals prepares to take the helm, the families are meticulously restructuring their operations, balancing their intensely private heritage with the looming prospect of a blockbuster public listing.